GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$16.3M
Doctors Paid
10,200
Transactions
28,935
2024 Total
$39,958
Payment Breakdown by Category
Research$12.0M (73.8%)
Consulting$1.4M (8.5%)
Travel$811,441 (5.0%)
Food & Beverage$662,114 (4.1%)
Royalty/License$13,888 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research
$12.0M
2,206 transactions
General
$4.3M
26,729 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 8
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Laarnie Chaco, Physician Assistant, PHYSICIAN ASSISTANT | Physician Assistant | Gresham, OR | $399.72 | $0 |
| Vinayak Belamkar, Md, MD | Anesthesiology | Indianapolis, IN | $392.00 | $0 |
| Dr. Richard Jacoby, Dpm, DPM | Podiatrist | Scottsdale, AZ | $388.46 | $0 |
| Dr. Benjamin Mcgrath, Dpm, DPM | Podiatrist | Los Angeles, CA | $384.79 | $0 |
| Christine Kirk, Np, NP | Adult Health | Audubon, NJ | $383.55 | $0 |
| Dr. Michael Wong, Md, MD | Pain Medicine | Bel Air, MD | $381.72 | $0 |
| Adam Shapiro | Primary Podiatric Medicine | Upland, CA | $381.11 | $0 |
| Dr. Jay Lafleur, Md, MD | Anesthesiology | Pearland, TX | $374.55 | $0 |
| Dr. Matthew Mertz, Dpm, DPM | Foot Surgery | Lehighton, PA | $373.47 | $0 |
| Clara Goodman | Physician Assistant | Gilbert, AZ | $368.68 | $0 |
| Dr. David Glick, D.c, D.C | Neurology | Richmond, VA | $364.00 | $0 |
| Malik Momin, M.d, M.D | Anesthesiology | Harrisburg, PA | $363.00 | $0 |
| Mr. Octavian Sharp, Fnp, FNP | Family | Memphis, TN | $362.09 | $0 |
| Zachary Lerner, Aprn, APRN | Nurse Practitioner | Overland Park, KS | $361.41 | $0 |
| Dr. Gigi Geiger, Do, DO | Pain Medicine | Jacksonville, FL | $360.36 | $0 |
| Unknown Provider | — | — | $358.44 | $0 |
| Dr. Michael Paula, Dpm, DPM | Foot & Ankle Surgery | Miami, FL | $357.23 | $0 |
| Dr. Robert Odell, M.d., Ph.d, M.D., PH.D | Pain Medicine | Las Vegas, NV | $355.20 | $0 |
| Tamara Miller, M.d, M.D | Specialist | Fort Collins, CO | $353.01 | $0 |
| Dr. William Caldwell, D.o, D.O | Pain Medicine | Stony Brook, NY | $350.53 | $0 |
| Srinivas Nalamachu, Md, MD | Physical Medicine & Rehabilitation | Overland Park, KS | $348.14 | $0 |
| Amr Morsy, Md, MD | Anesthesiology | Rockwall, TX | $344.04 | $0 |
| Nanichi Ramos Roldan | Physical Medicine & Rehabilitation | Philadelphia, PA | $343.74 | $0 |
| Jason Kim, Dpm, DPM | Foot & Ankle Surgery | New York, NY | $343.67 | $0 |
| Madeleine Hill, Pa, PA | Physician Assistant | Oklahoma City, OK | $343.63 | $0 |
Ad
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.